{"disease":{"id":"nephrotic-syndrome-idiopathic","name":"nephrotic syndrome idiopathic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03786263","title":"CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT05914155","title":"Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"Shoichi Maruyama MD PhD","has_results":false},{"nct_id":"NCT06635720","title":"REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT04456816","title":"A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":23,"lead_sponsor_name":"SynAct Pharma Aps","has_results":false},{"nct_id":"NCT04034316","title":"Reduce Immunosuppression With Atmp in NS ChildrEn","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}